Access cutting-edge temporal lobe epilepsy treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access temporal lobe epilepsy specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related temporal lobe epilepsy treatment provided free
The main goals of this clinical study are to learn if AMT-260 is safe and tolerable and works to reduce the frequency of seizures in adults with unilateral mesial temporal lobe epilepsy (MTLE).
Sponsor: UniQure Biopharma B.V.
Check if you qualify for this temporal lobe epilepsy clinical trial in Baltimore, MD
If you're searching for temporal lobe epilepsy treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced temporal lobe epilepsy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.